baber/WOPTO huggingface dataset:
Patent AU-754759-B2 (AU)
Title: Device and method for medical treatment
Inventor: WALLSTEN HANS I
IPC: A61F7/08
Filed: 1999-12-16
Granted: 2002-11-21
Abstract: A device for carrying out hyperthermia in a mammalin uterus cavity, including an elongate, rigid distal section (3) and a flexible and elastic bladder (9) encompassing said distal section which, together with said bladder, is intended for insertion into said uterus cavity, further including means (27) for the supply of a heat-transmitting medium under pressure for the expansion of said bladder (9) within said uterus cavity, and heating means (29) for heating said medium, the device further having an intermediate section (5) whose distal part when inserted is positioned in a cervix canal belonging to said uterus, and a proximal section (7) for operating the device, said distal and intermediate sections (3,5) containing at least a central tube (17), whose distal part is surrounded by said bladder and is provided with at least one outlet (19) for said medium within said bladder, and whose intermediate part is surrounded by an axially displacable tube (21;35), onto whose distal end (23;51) the proximal end (25) of said bladder (9) is attached, characterized by means (15;45) for determining the axial position of the distal end (23;51) of said axially displacable tube and thereby also the axial position of the proximal end (25) of said bladder (9) so that the length of said bladder (9) matches the depth of a cavity subject to treatment, and means (13;47) for locking said tube (21;35) with its distal end (25;51) in such matching position; and the invention also involves methods of thermal treatment of human uterus cavity linings and a device for thermal treatment of mammalian body cavities or ducts, such as urethras.
Patent AU-758273-B2 (AU)
Title: Improved distal end for ligating band dispenser
Inventor: FORTIER RICHARD C
IPC: A61B19/00
Filed: 1999-04-09
Granted: 2003-03-20
Abstract: A supporting structure for a ligating band dispensing device adapted to be coupled to a distal end of an endoscope comprises a substantially cylindrical outer support surface adapted to receive a plurality of ligating bands thereon, wherein the support surface includes a channel extending therethrough from a distal end to a proximal end. The support surface further includes a plurality of shallow slots and deeper slots disposed on the distal end for retaining a trigger string. The shallow slots and deeper slots may be arranged in an alternating fashion, and each of the slots may be narrower than the trigger string to prevent the trigger string from prematurely exiting the slots. <IMAGE>
Patent AU-717341-B2 (AU)
Title: Float switch
Inventor: BATCHELDER SCOTT T
IPC: H01H35/18
Filed: 1997-09-09
Granted: 2000-03-23
Abstract: A float switch having a housing, a pivoting float body and a tube containing mercury. The wires extend from the tube, into pivot arms of the float body, out of apertures within the arms and upwardly out an orifice in the top surface of the housing. The pivot arms indude a pivot arm stop to center the float body within the housing. The pivot arms are sealed to prevent ingress of water into the tube. The housing indudes dual rows of apertures to lessen the effects of clogging. <IMAGE>
Patent AU-621133-B2 (AU)
Title: Gelatine granules as well as methods and apparatus for their manufacture
Inventor: KOEPFF PETER DR
IPC: C09H9/04
Filed: 1989-07-21
Granted: 1992-03-05
Abstract: Gelatin granules obtained by plasticising conventional gelatin comprise solid gelatin particles having a water content of 1 - 12% by weight, a grain size of 0.1 - 10 mm, a content of air inclusions of less than 1% by volume and a melt flow index of greater than 1 g/10 min at 110 DEG C. The granules have thermoplastic properties and, like conventional plastics, can be processed by extrusion, injection moulding, blowing and the like to give solid or hollow mouldings.
Patent AU-615562-B2 (AU)
Title: Substituted 2,6-substituted 1,2-or 1,6-dihydro pyridine compounds
Inventor: CHUPP JOHN PAUL
IPC: C07D211/72
Filed: 1989-07-28
Granted: 1991-10-03
Abstract: Compounds of general formula <CHEM>  wherein:  one of Y1 and Y2 is <CHEM>  in which Z1 is selected from -SR, -OR, <CHEM> where R, R4 and R5 are the same or different and are selected from alkyl, alkenyl, alkynyl, haloalkyl, haloalkenyl, and cyanoalkyl, and <CHEM> is selected from azetidinyl and a saturated or unsaturated 5-membered heterocyclic ring moiety containing 1-2 nitrogen atoms, the remaining atoms being carbon atoms, optionally substituted with 1 to 3 groups which are the same or different and are selected from alkyl, alkoxy, cyano, halo, nitro, haloalkyl, alkoxyalkyl, and dialkoxyalkyl; Z2 is selected from O and S;  the other of Y1 and Y2 is <CHEM>  where <CHEM>  is as defined above; R1 and R2 are independently selected from fluorinated methyl, chlorofluorinated methyl, chlorinated methyl, and lower alkyl radicals, provided that one of R1 and R2 must be a fluorinated methyl or chlorofluorinated methyl radical; X is selected from lower alkyl, cycloalkylalkyl, alkoxyalkyl and alkylthioalkyl, useful as halicids.
Patent AU-715590-B2 (AU)
Title: System for producing time-independent virtual camera movement in motion pictures
Inventor: TAYLOR DAYTON V
IPC: G03B19/02
Filed: 1995-12-05
Granted: 2000-02-03
Abstract: A system for producing virtual camera motion in a motion picture medium in which an array of cameras (10) is deployed along a preselected path with each camera (10) focused on a common scene (12). Each camera (10) is triggered simultaneously to record a still image of the common scene (12), and the images are transferred from the cameras (10) in a preselected order along the path onto a sequence of frames in the motion picture medium such as motion picture film (20) or video tape. Because each frame shows the common scene (12) from a different viewpoint, placing the frames in sequence gives the illusion that one camera (10) has moved around a frozen scene (i.e., virtual camera motion). In another embodiment, a two-dimensional array (1100) of video cameras (1102) is employed. Each camera (1102) synchronously captures a series of images in rapid succession over time. The resulting array of images can be combined in any order to create motion pictures having a combination of virtual camera motion and time-sequence images. <IMAGE>
Patent AU-661793-B2 (AU)
Title: Process for preparing carbapenem and penem compounds and new compounds involved in that process
Inventor: YOSHIDA AKIRA
IPC: A61K31/43
Filed: 1993-09-09
Granted: 1995-08-03
Abstract: Penem and carbapenem compounds having a group of formula -SA are prepared from a corresponding compound having a substituted thio, sulphinyl or sulphonyl group at this position by reaction with a compound ASH (where A is various organic groups) in the presence of a salt of a metal of Group II or III of the Periodic Table.
Patent AU-710527-B2 (AU)
Title: Amino acid compositions and use thereof in clinical nutrition
Inventor: SCHNEIDER HEINZ
IPC: A23L1/305
Filed: 1996-02-22
Granted: 1999-09-23
Abstract: The invention provides the use of at least one amino acid selected from the group consisting of glycine, alanine and serine, or the physiologically acceptable salts thereof, in the preparation of a medicament or nutritional formulation for the diminution of tumor necrosis factor (TNF) levels in patients in whom said levels are elevated beyond those which mediate physiological homeostasis and local inflammation. Such diminution of TNF levels can i.a. be achieved by inhibition or diminution of: (i) tumor necrosis factor (TNF) production by macrophage-type cells; (ii) the release of TNF from macrophage-type cells; and/or (iii) the binding of TNF by TNF receptors.
Patent AU-615372-B2 (AU)
Title: Method of and apparatus for making mineral insulated cable and mineral insulated cable made by such method or apparatus
Inventor: GILL DENNIS
IPC: H01B7/16
Filed: 1990-01-25
Granted: 1991-09-26
Abstract: Blocks (60, 65) of magnesium oxide or other mineral insulant are formed with grooves (62). Copper conductors (63) are laid in the grooves (62) and the blocks (60, 65) are held in place on the conductors (63) by a layer of insulating tape (66). A copper tube (68) is formed around the layer (66), and the whole is then subjected to alternating steps of drawing or rolling and annealing to form a mineral insulated cable.
Patent AU-776921-B2 (AU)
Title: Arrayed waveguide gratings
Inventor: ROGERS DAVID CARNEGIE
IPC: G02B6/12
Filed: 2000-05-19
Granted: 2004-09-23
Abstract: A method of producing a planar waveguiding device having a core [10] and a cladding [17]. The cladding has groves [11,12] directly interfacing [15,16] with the core [10]. A layer of core glass [10] is deposited on the surface of a substrate [23,24]. This layer is etched to produce a shaped layer which includes a first core portion [10] having the same configuration as the intended core [10] and an expanded core portion [30] wherein the core glass extends beyond the intended core boundary. A glass covering layer [21] is deposited over the etched core glass and grooves [11,12] are produced by etching through the covering layer [21] and into said expanded core portion [30]. This removes the core glass [30] extending beyond the intended core [10] boundary to produce interfaces [15,16] between the core [10] and the grooves [11,12]. All of the glasses are silica with additives to adjust the refractive index and/or the melting point.
Patent AU-661620-B2 (AU)
Title: Synergistic composition and process for selective weed control
Inventor: GUT HANS
IPC: A01N47/36
Filed: 1993-04-23
Granted: 1995-07-27
Abstract: Herbicidal composition comprising N-[2-(3,3,3-trifluoropropyl)-phenylsulfonyl]-N'-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-urea of the formula I    <IMAGE>  (I)  or agrochemically tolerated salts thereof, and a synergistic amount of another active substance 3,5-dibromo-4-hydroxybenzonitrile of the formula II    <IMAGE>  (II)
Patent AU-624494-B2 (AU)
Title: A method of preparing a freeze-dried formulation containing a drug
Inventor: UEDA SEIGO
IPC: A23L3/44
Filed: 1990-04-17
Granted: 1992-06-11
Abstract: In a freeze-drying method for producing a dried pharmaceutical compound or preparation, a first liquid is frozen, a second liquid is added to the frozen first liquid and is frozen thereon, and the frozen first and second liquids are freeze-dried together, in which at least one of said first and second liquids contains said pharmaceutical compound or preparation dissolved or suspended therein. The other liquid or liquids may be pure solvent (generally water) or may contain one or more other substances.
Patent AU-534269-B2 (AU)
Title: Rock drill support
Inventor: MONTABERT ROGER
IPC: E21B15/04
Filed: 1980-03-26
Granted: 1984-01-12
Abstract: A mining drill comprising a rail along which a mining drill head is slidably rectilinear, this rail being carried by a hydraulic motor pivotally connected to a rotary head at the end of an arm swingable about a pivot axis which is generally horizontal and is formed by a column or post. A first hydraulic motor is provided to rotate the post about a generally upright axis and hydraulic cylinders can be provided to swing the post about a pivot close to its pedestal. The device is designed to support the rail so that substantially parallel holes can be drilled in a subterranean structure in practically any direction, e.g. with any inclination to the axis of the main gallery, but especially parallel thereto.
Patent AU-676004-B2 (AU)
Title: Copolyamide for use in a barrier layer
Inventor: PRESENZ ULRICH
IPC: B65D65/40
Filed: 1994-03-23
Granted: 1997-02-27
Abstract: The invention relates to a barrier layer resisting the transmission of oxygen for multi-layer barrier film characterized in that it is made of a transparent copolyamide comprising three components. The first component is hexamethylenediamine and adipic acid. The second component is hexamethylenediamine and azelaic acid, hexamethylenediamine and sebacic acid, and mixtures thereof. The third component is hexamethylene-diamine and isophthalic acid, hexamethylenediamine and terephthalic acid, and mixtures thereof. The total of all components is 100 mol %, and the ratio of the barrier effects in the barrier layer with respect to carbon dioxide and oxygen is at least 3:1.
Patent AU-634247-B2 (AU)
Title: Antitumor substance be-13793c
IPC: A61K31/40
Filed: 1990-06-20
Granted: 1993-02-18
Abstract: A novel antitumor substance BE-13793C or a pharmaceutically acceptable salt thereof, which is represented by the following formula: <CHEM> an anticancer agent comprising the novel substance or a pharmaceutically acceptable salt thereof, a method of producing the novel substance and a microorganism capable of producing the novel substance are disclosed.
Patent AU-737312-B2 (AU)
Title: Treatment and prevention of adhesions
Inventor: PINES MARK
IPC: A61P17/02
Filed: 1998-02-11
Granted: 2001-08-16
Abstract: An inhibitor of adhesion formation which can be used to prevent adhesions within the abdominal cavity, particularly following surgical intervention, trauma or inflammation in the area is disclosed. Specifically, the most preferred compound of the present invention. Halofuginone, can be used to prevent collagen deposition from occurring within the peritoneum after surgical intervention, thereby inhibiting adhesion formation. Halofuginone, and related compounds, are useful in the prevention and treatment of both inflammatory and surgically induced adhesions, and in the treatment of congenital adhesions.
Patent AU-698086-B2 (AU)
Title: Process and device for authenticating subscribers to digitalexchanges
Inventor: STOLZ HELMUT
IPC: H04Q11/04
Filed: 1996-06-08
Granted: 1998-10-22
Abstract: A device for authenticating subscribers to one or more exchanges of a digital communication network having at least one subscriber-side network terminator, to which at least one data terminal may be connected. It is a distinction of the invention that provision is made at every subscriber for at least one first authentication module capable of receiving a first identification carrier, and provision is made in the exchange for at least one second authentication module capable of receiving a second identification carrier, or that, alternatively, connected between the network terminators assigned to the exchange and the exchange is an additional device, in which is arranged a second authentication module capable of receiving a second identification carrier, the authentication modules being capable of encoding and/or decoding a piece of information with an individual, subscriber-specific key and of exchanging information with each other for unilateral and/or bilateral authentication.
Patent AU-775519-B2 (AU)
Title: Imaging the dopamine transporter to determine AD-HD
Inventor: MADRAS BERTHA K
IPC: A61K31/421
Filed: 2000-06-28
Granted: 2004-08-05
Abstract: A method of diagnosing attention deficient-hyperactivity disorder (AD-HD) in a human patient by assessing dopamine transporter in at least one region of the patient's central nervous system, where an elevated level of dopamine transporter in the patient is indicative of AD-HD. In embodiments of the invention, assessment of dopamine transporter levels includes assessing binding of a dopamine transporter ligand to dopamine transporter using PET or SPECT.
Patent AU-590581-B2 (AU)
Title: Absorbent structures
Inventor: WONG ARTHUR
IPC: B01D15/00
Filed: 1986-06-27
Granted: 1989-11-09
Abstract: The present invention relates to absorbent structures in which hydrogel has improved ability to absorb salt-containing fluids due to inclusion within the absorbent structures of fibrous anion exchange materials. The absorbent structures of the present invention comprise hydrogel and fibrous anion exchange material (e.g., DEAE cellulose), and, optionally, fibrous cation exchange materials and/or conventional absorbent materials; said absorbent structures having an equilibrium pH of from about 5 to about 11. The present invention further relates to disposable absorbent products (e.g., diapers, incontinent pads, sanitary, napkins) which comprise absorbent structures of the present invention.
Patent AU-575011-B2 (AU)
Title: Sintered silicon carbide ceramic body of high electrical resistivity
Inventor: BOECKER WOLFGANG D G
IPC: C04B35/56
Filed: 1986-08-13
Granted: 1988-07-14
Abstract: Sintered silicon carbide body having a D.C. electrical resistivity of at least 10<sup>8</sup> Ohm cm at 25°C, a density of at least 2.95 g/cm<sup>3</sup> is formed upon sintering in a nitrogenous atmosphere at a temperature of about 2250°C or greater, a shaped body composed essentially of carbon or carbon source material in amount sufficient to provide up to 2.5 percent uncombined carbon; from about 0.4 to about 2.0 percent boron carbide; up to 25 percent of temporary binder and a balance of silicon carbide which is predominately alpha-phase. The shaped body additionally include other sintering aids such as Bn or A1 without destruction of desired high electrical resistivity.
Patent AU-666440-B2 (AU)
Title: Tetrazole derivatives of bile acids, processes for their preparation and the use of these compounds as medicaments
Inventor: ENHSEN ALFONS
IPC: A61K31/575
Filed: 1994-05-06
Granted: 1996-02-08
Abstract: Tetrazole bile acid derivatives of the formula I  G1 - X - G2      I in which G1, G2 and X have the stated meanings, and processes for their preparation are described. The compounds have valuable pharmacological properties and can therefore be used as medicines.
Patent AU-723158-B2 (AU)
Title: Fluorescence resonance energy transfer screening assay for the identification of HIV-1 envelope glycoprotein-medicated cell
Inventor: ALLAWAY GRAHAM P
IPC: C07K16/28
Filed: 1996-06-07
Granted: 2000-08-17
Abstract: This invention provides: agents determined to be capable of specifically inhibiting the fusion of a macrophage-tropic primary isolate of HIV-1 to a CD4+ cell, but not a T cell-tropic isolate of HIV-1 to a CD4+ cell; and agents determined to be capable of specifically inhibiting the fusion of a T cell-tropic isolate of HIV-1 to a CD4+ cell, but not a macrophage-tropic primary isolate of HIV-1 to a CD4+ cell. This invention also provides: agents capable of specifically inhibiting the fusion of a macrophage tropic primary isolate of HIV-1 with a CD+ cell susceptible to infection by a macrophage-tropic primary isolate of HIV-1; and agents capable of specifically inhibiting the fusion of a T cell-tropic isolate of HIV-1 with a CD4+ cell susceptible to infection by a T cell-tropic isolate of HIV-1. The agents include but are not limited to antibodies. This invention further provides: methods of inhibiting fusion of a macrophage-tropic primary isolate of HIV-1 with a CD+ cell susceptible to infection by a macrophage-tropic primary isolate of HIV-1 which comprises contacting the CD4+ cell with an amount of an agent capable of specifically inhibiting such fusion so as to thereby inhibit such fusion; and methods of inhibiting fusion of a T cell-tropic isolate of HIV-1 with a CD4+ cell susceptible to infection by a T cell-tropic isolate of HIV-1 which comprises contacting the CD4+ cell with an amount of an agent capable of specifically inhibiting such fusion so as to thereby inhibit such fusion.
Patent AU-621277-B2 (AU)
Title: Shortened phosphoglycerate kinase promoter
Inventor: LEE JAR-HOW
IPC: C12P21/00
Filed: 1986-11-13
Granted: 1992-03-12
Abstract: A shortened PGK promoter of the PGK gene comprising less than 500 base pairs of the proximal end of the 5' region of the PGK gene. The invention also provides for vehicles capable of replication and expression comprising said shortened PGK promoter operably linked to a structural gene and operably linked to a secretion signal linked to a structural gene, and also provides for hosts transformed with the vehicle. In one embodiment of the invention disclosed, the shortened PGK promoter is used with a process for regulating yeast plasmid copy number by two selectable markers, the first marker having normal or high level expression from its promoter, the second marker, leu2-d, having low level expression from its promoter. Expression of a structural gene on this plasmid system can be increased by lowering the level of the second metabolite (leucine) in the growth medium, thereby selecting for an increased copy number of the second selectable marker (leu2-d), and therefore increased plasmid copy number, which in turn increases the number of copies of the structural gene being expressed.
Patent AU-541648-B2 (AU)
Title: Telephone ring signalling system
Inventor: DAS SANTANU
IPC: H04M19/02
Filed: 1981-03-26
Granted: 1985-01-17
Abstract: 1. Method of providing ringing signals the composition and duration of which are determined by ringing circuits (74-78) and by ringing supervision circuits (122-124) for a plurality of telecommunication lines (42 to 48) interconnectable via a switching network, the connection status of said lines being supervised line by line and said lines being connectable group by group, via a common ringing signal bus (82), to a common ringing circuit (74-78) and connected group by group each with a ringing answering detector (122), especially for digital telephone switching systems in which the analogic number lines are connected to the switching network via line termination circuits (12) in which conversion takes place between the analog signals on the subscriber line and the digital signals in the switching network, characterized in, that in the ringing circuit (74-78) a.c. voltages of different frequencies (f1 to f4), generated from several ringing signal reference voltage sources (100 to 106), are transmitted to the common ringing signal bus (82) as an amplified a.c. ringing voltage depending on control signals provided by ringing interval detectors (124), that the ringing a.c. voltages are supplied to the connecting circuits (50 to 56) of the corresponding group (0) of telecommunication lines (42 to 48) via the ringing signal bus (82), that the control signals supplied by the ringing interval detectors (124) are also supplied to the connecting circuits (50 to 56) of the corresponding group (0) of telecommunication lines (42 to 48), that in the connecting circuits (50 to 56) each individual telecommunication line is connected to the ringing signal bus (82) at the correct time on the basis of the control signals formed by the ringing interval detector (124) depending on the ringing status on the ringing signal bus (82), and that in the corresponding connecting circuit (50-56) the connecting of a telecommunication line to be run to the ringing signal bus is controlled in such a way that the telecommunication line receives immediate ringing by this path.
Patent AU-721139-B2 (AU)
Title: Pyridazino quinoline compounds
Inventor: BARE THOMAS MICHAEL
IPC: C07D215/56
Filed: 1998-05-27
Granted: 2000-06-22
Abstract: (4,5-b)quinoline-1,10-dione derivs. and tricyclic hetero-fused pyridazino-pyridine analogues of formula (I) and their salts and tautomers are new, including B-ring tautomers or reduced derivs. of formula (I'):Z = O, S or NH; Z1 = H, OH, SH or NH2; ring A = ortho-fused phenyl, pyridyl, furyl,etc.; R4 = halo, Q, NO2, CN, 1-3C perfluoroalkyl, OH,etc.;R1 = H or -(CH2)nL; L = M or W; M = e.g. (i) phenyl (or benzo deriv.), opt. substd. by 1-4 of OQ, 2-4C alkenyloxy, 2-4C alkynyloxy,-OCOQ'-phenyl,etc.;(ii) 5-7 membered heterocyclyl contg. 1-3 of O, N and S as heteroatoms,etc.;or (iii) heteroaryl (or benzy deriv.) including pyridyl, thienyl, furyl, gps. contg. 2 heteroatoms selected from N, O and S (e.g. pyrazole, imidazol etc.);W = OH, ORa, OCORa, S(O)mRa, S(O)mNRaRb,etc.;W may also be CORa, NRaCORb,etc., if n is other than zero; n = 0-6;R2 = H or (CH2)nL'; L' = M' or W; M' = e.g. (i) phenyl (or benzo deriv.), opt. substd. by 1-3 of 1-3 of OQ, OH, halo, NO2,etc.; R = H or Q; Ra,Rb = H, Q, 2-4C alkenyl, 2-4C alkynyl,etc.; m = 0-2; Q = 1-4C alkyl (or alkylene if appropriate); Q' = 1-6C alkyl (or alkylene if appropriate); provided that R1 and R2 are not both H.